Clincosm LogoSign in Get a demo

Peripheral T-cell Lymphoma

Showing 26 - 50 of 90
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia, Peripheral T-cell Lymphoma Trial in United States (20 mg/kg TRU-016 + Rituximab, 10 mg/kg TRU-016

Terminated
  • Chronic Lymphocytic Leukemia
  • Peripheral T-cell Lymphoma
  • 20 mg/kg TRU-016 + Rituximab
  • +5 more
  • Augusta, Georgia
  • +7 more
May 18, 2021

Peripheral T-cell Lymphoma Trial in Shanghai (BEAC, Cladribine combined with BEAC)

Recruiting
  • Peripheral T-cell Lymphoma
  • BEAC
  • Cladribine combined with BEAC
  • Shanghai, Shanghai, China
    Ruijin Hospital
May 9, 2021

Peripheral T-cell Lymphoma Trial in Singapore (Selinexor, ICE Chemotherapy)

Completed
  • Peripheral T-cell Lymphoma
  • Singapore, Singapore
    National Cancer Centre Singapore
Apr 27, 2021

Peripheral T-cell Lymphoma Trial in Beijing (Sintilimab, Chidamide, Azacidine)

Not yet recruiting
  • Peripheral T-cell Lymphoma
  • Beijing, Beijing, China
    Beijing
Mar 5, 2021

Peripheral T-cell Lymphoma, Cutaneous T-cell Lymphoma Trial in Stanford (KW-0761)

Completed
Has Results
  • Peripheral T-cell Lymphoma
  • Cutaneous T-cell Lymphoma
  • KW-0761
  • Stanford, California
    Stanford University
Dec 3, 2020

Peripheral T-Cell Lymphoma Trial in United States (KW-0761)

Completed
Has Results
  • Peripheral T-Cell Lymphoma
  • KW-0761
  • Los Angeles, California
  • +4 more
Dec 3, 2020

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +35 more
  • Akt inhibitor MK2206
  • laboratory biomarker analysis
  • Houston, Texas
    M D Anderson Cancer Center
Oct 14, 2020

Peripheral T-cell Lymphoma Trial in Beijing, Shanghai (TQ-B3525)

Unknown status
  • Peripheral T-cell Lymphoma
  • Beijing, Beijing, China
  • +1 more
Oct 30, 2020

Peripheral T-cell Lymphoma Trial in Seoul (CHOP, fractionated ICED)

Recruiting
  • Peripheral T-cell Lymphoma
  • Seoul, Seoul, Korea, Republic Of, Korea, Republic of
    Samsung Medical Center
Oct 21, 2020

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +18 more
  • Scottsdale, Arizona
  • +1 more
Sep 28, 2020

Solid Tumor, Lymphoma, Peripheral T-Cell Lymphoma Trial in United States (ALRN-6924)

Completed
  • Solid Tumor
  • +2 more
  • Birmingham, Alabama
  • +12 more
Jul 13, 2020

Peripheral T-Cell Lymphoma Trial in Worldwide

Recruiting
  • Peripheral T-Cell Lymphoma
    • Stanford, California
    • +5 more
    Jul 8, 2020

    Peripheral T-cell Lymphoma Trial in Zhengzhou (PD-1 blocking antibody, chidamide, lenalidomide and gemcitabine)

    Unknown status
    • Peripheral T-cell Lymphoma
    • PD-1 blocking antibody, chidamide, lenalidomide and gemcitabine
    • Zhengzhou, Henan, China
      Oncology Department of The First Affilliated Hospital of Zhengzh
    May 9, 2020

    Peripheral T-Cell Lymphoma Trial in Saint Louis (Gemcitabine, Navelbine, Doxorubicin Hydrochloride Liposome Injection)

    Terminated
    Has Results
    • Peripheral T-Cell Lymphoma
    • Saint Louis, Missouri
      Washington University
    Apr 14, 2020

    Peripheral T-cell Lymphoma Trial in Worldwide (Romidepsin)

    Completed
    Has Results
    • Peripheral T-cell Lymphoma
    • La Jolla, California
    • +89 more
    Jan 29, 2020

    Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

    Completed
    Has Results
    • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
    • +99 more
    • alemtuzumab
    • +6 more
    • Denver, Colorado
    • +6 more
    Jan 15, 2020

    Acute Undifferentiated Leukemia, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma Trial in

    Completed
    • Acute Undifferentiated Leukemia
    • +63 more
    • total-body irradiation
    • +7 more
    • Seattle, Washington
    • +1 more
    Jan 17, 2020

    Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic

    Completed
    • Acute Myeloid Leukemia/Transient Myeloproliferative Disorder
    • +76 more
    • fludarabine phosphate
    • +6 more
    • Tucson, Arizona
    • +10 more
    Jan 17, 2020

    Comprehensive Oncology Measures for Peripheral T-cell Lymphoma

    Completed
    • Peripheral T-cell Lymphoma
      • Tuscaloosa, Alabama
      • +67 more
      Jan 8, 2020

      Relapsed or Refractory Lymphoproliferative Malignancies, Hodgkin's Lymphoma, Peripheral T-cell Lymphoma Trial in United States

      Completed
      Has Results
      • Relapsed or Refractory Lymphoproliferative Malignancies
      • +4 more
      • Pralatrexate Injection
      • +3 more
      • Los Angeles, California
      • +14 more
      Dec 27, 2019

      Peripheral T-cell Lymphoma Trial in United States (Belinostat, CHOP)

      Completed
      • Peripheral T-cell Lymphoma
      • New Haven, Connecticut
      • +7 more
      Dec 31, 2019

      Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

      Completed
      • Adult Nasal Type Extranodal NK/T-cell Lymphoma
      • +35 more
      • Duarte, California
      • +4 more
      Dec 24, 2019

      Peripheral T-cell Lymphoma Trial in Worldwide (Pralatrexate Injection)

      Completed
      Has Results
      • Peripheral T-cell Lymphoma
      • Pralatrexate Injection
      • Duarte, California
      • +31 more
      Dec 9, 2019

      Adult T-cell Leukemia-Lymphoma, Peripheral T-cell Lymphoma Trial in Japan (Lenalidomide)

      Completed
      • Adult T-cell Leukemia-Lymphoma
      • Peripheral T-cell Lymphoma
      • Fukuoka, Japan
      • +5 more
      Nov 6, 2019

      Peripheral T-cell Lymphoma Trial in Italy (Romidepsin + Gemcitabine)

      Completed
      Has Results
      • Peripheral T-cell Lymphoma
      • Romidepsin + Gemcitabine
      • Alessandria, Italy
      • +3 more
      Oct 11, 2019